Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
Asunto de la revista
Intervalo de año de publicación
1.
Vestn Ross Akad Med Nauk ; (3): 24-33, 2007.
Artículo en Ruso | MEDLINE | ID: mdl-17500211

RESUMEN

The opioid system is one in a number of peptidergic regulatory systems that support an appropriate anxiety level. The drugs that interact with the opioid system have been shown to influence anxiety, although there is a notable variability in their pharmacological effects. Biological mechanisms of this variability are considered to be the heterogeneity of opioid receptors, the ratio of the processes of their expression and desensitization, and the balance between the synthesis and degradation of endogenous opioid peptides. For instance, the anxiolythic effect of the synthetic derivate of enkephalin in rats was detected after stress-induced exhaustion of endogenous opioids, and its efficacy depended on the degree of delta- and mu-opioid receptor desensitization in some brain regions. The anxiolythic properties of the heptapeptide Selanc that has also been shown to affect the opioid system are most prominent in subjects with elevated activity of enzymes degrading endogenous opioid peptides. Thus, delicate correction of the opioid system with drugs of peptide nature is supposed to become a new approach to treatment of some forms of anxiety disorders accompanied with exhaustion of the endogenous opioid system and, in particular, of generalized anxiety disorder.


Asunto(s)
Ansiolíticos/farmacología , Trastornos de Ansiedad/tratamiento farmacológico , Oligopéptidos/farmacología , Animales , Ansiolíticos/uso terapéutico , Química Encefálica/efectos de los fármacos , Modelos Animales de Enfermedad , Encefalinas/farmacología , Masculino , Ratones , Ratones Endogámicos BALB C , Naloxona/farmacología , Antagonistas de Narcóticos/farmacología , Oligopéptidos/uso terapéutico , Péptidos Opioides/metabolismo , Ratas , Receptores Opioides/efectos de los fármacos
2.
J Neuroimmunol ; 117(1-2): 68-77, 2001 Jul 02.
Artículo en Inglés | MEDLINE | ID: mdl-11431006

RESUMEN

The purpose of this study was to evaluate mu- and delta-opioid receptors (OR) on human and murine dendritic cells (DC). Expression of mu- and delta-OR mRNA on DC was demonstrated by RT-PCR. The immunocytochemical and Western blot analyses revealed the expression of OR protein in DC. Radioreceptor assay demonstrated the specific saturated temperature-dependent binding of [3H]-labeled opioid ligand on DC and B(max)=2.8+/-0.3 fmol/10(6) cells and K(D)=4.8+/-1.0 nM were calculated by a Scatchard analysis. Finally, OR ligands DADLE and DAGO dose-dependently modulated the capacity of DC to induce T cell proliferation in an MLR assay. Importantly, expression of functional OR on DC was significantly increased upon TNF-alpha-induced DC maturation. Thus, these data suggest a new mechanism of opioid-dependent neuroendocrine immunomodulation.


Asunto(s)
Células Dendríticas/química , Receptores Opioides delta/análisis , Receptores Opioides mu/análisis , Animales , Células Cultivadas , Humanos , Inmunohistoquímica , Masculino , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , ARN Mensajero/análisis , Receptores Opioides delta/genética , Receptores Opioides delta/fisiología , Receptores Opioides mu/genética , Receptores Opioides mu/fisiología , Factor de Necrosis Tumoral alfa/farmacología
3.
Bioorg Khim ; 26(7): 512-5, 2000 Jul.
Artículo en Ruso | MEDLINE | ID: mdl-11008641

RESUMEN

A [3H]Dalargin preparation with a molar radioactivity of 52 Ci/mmol was obtained by the high temperature solid-state catalytic isotope exchange (HSCIE) of tritium for hydrogen at 150 degrees C. This tritium-labeled peptide was shown to completely retain its biological activity in the test of binding to opioid receptors from rat brain. The dissociation constant of the Dalargin-opioid receptor complex was found to be 4.3 nM. The dependencies of the chemical yield and the molar radioactivity on the reaction time and temperature of HSCIE were determined. The activation energy of the HSCIE reaction for the peptide was calculated to be 32 kcal/mol. The amino acid analysis showed that tritium is distributed between all the amino acid residues of [3H]Dalargin at the HSCIE reaction, with the temperature growth significantly increasing the total tritium incorporation and, especially, enhancing the radioactivity incorporation into aromatic residues.


Asunto(s)
Leucina Encefalina-2-Alanina/análogos & derivados , Leucina Encefalina-2-Alanina/química , Animales , Encéfalo/metabolismo , Catálisis , Leucina Encefalina-2-Alanina/metabolismo , Técnicas In Vitro , Marcaje Isotópico , Membranas , Ensayo de Unión Radioligante , Ratas , Receptores Opioides/metabolismo , Temperatura , Termodinámica , Tritio
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA